All Stories

  1. CDKN2A homozygous deletions and TSC2 somatic mutations in metastatic pancreatic neuroendocrine tumors
  2. 37th European Congress of Pathology - Abstracts
  3. Herpes Simplex Virus Type-1 Infection as a Trigger for Pemphigus Vulgaris
  4. Buschke-Lowenstein Tumor: An Unusual Therapeutic Approach
  5. Cutaneous lesions and articular manifestations in multicentric reticulohistiocytosis: a diagnostic challenge
  6. Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS Syndrome
  7. Histopathological and Clinical-Genetic Analysis of Corneal Specimens in Maroteaux–Lamy Syndrome
  8. Expert consensus and current landscape of NUT carcinoma: A comprehensive strategy from diagnosis to treatment
  9. Biomarker Profiling of Upper Tract Urothelial Carcinoma Only and with Synchronous or Metachronous Bladder Cancer
  10. Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS Syndrome
  11. Cellular iron governs the host response to malaria
  12. LINFOMA DE HODGKIN
  13. Author Reply to Peer Reviews of Cellular iron governs the host response to malaria
  14. Generation of an Obese Diabetic Mouse Model upon Conditional Atrx Disruption
  15. Renovascular Hypertension: Unraveling a Case of Mixed Histiocytosis
  16. Abstract
  17. Cellular iron governs the host response to malaria
  18. Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
  19. An update on genetically engineered mouse models of pancreatic neuroendocrine neoplasms
  20. Clinicopathological features of head and neck cutaneous basal cell carcinoma observed at the Centro Hospitalar de Trás-os-Montes e Alto Douro ENT Department
  21. Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
  22. Primary adrenal angiosarcoma within a hematoma
  23. Connexin Expression in Pituitary Adenomas and the Effects of Overexpression of Connexin 43 in Pituitary Tumor Cell Lines
  24. Colonic Pseudolipomatosis: A Rare and Challenging Condition
  25. Predictive Biomarkers in Melanoma: Detection of BRAF Mutation Using Dermoscopy
  26. <b><i>TERT</i></b> Promoter Mutational Status in the Management of Cutaneous Melanoma: Comparison with Sentinel Lymph Node Biopsy
  27. TERTp mutations and p53 expression in head and neck cutaneous basal cell carcinomas with different aggressive features
  28. Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
  29. The role of c-Met and VEGFR2 in glioblastoma resistance to bevacizumab
  30. LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer
  31. Mohs Micrographic Surgery for Head and Neck Nonmelanoma Skin Cancer: An Approach for Ent Surgeons
  32. Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
  33. Clinical characteristics and incidence of glucose metabolism disorders during the follow-up of surgically treated insulinomas
  34. Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment
  35. Cutaneous Angiosarcoma in an Unusual Location and Without Predisposing Factors
  36. Embryonal Tumors of the Central Nervous System
  37. Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer
  38. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas
  39. Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”
  40. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study
  41. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
  42. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome
  43. Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?
  44. A leg ulcer with hard, yellow projections
  45. Juvenile gangrenous vasculitis of the scrotum – a diagnosis not to forget
  46. Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2
  47. Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism
  48. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  49. Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy
  50. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
  51. Perianal purpuric plaques revealing an amyloid light-chain amyloidosis: case report and review of the literature
  52. Periocular Sebaceous Carcinoma With Apocrine Differentiation: A Case Report and Review of the Literature
  53. Les mutations du promoteur de la télomérase sont un biomarqueur pronostique dans le carcinome épidermoïde cutané
  54. Histological Subtypes and Clinical Behavior Evaluation of Salivary Gland Tumors
  55. The genetics of cutaneous squamous cell carcinogenesis
  56. An unusual case of epistaxis due to angiofibroma of the nasal cavity
  57. Cutaneous amyloidosis as major manifestation of systemic AL-amyloidosis
  58. Melanoma treatment in review
  59. Telomere Maintenance Mechanisms in Cancer
  60. Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
  61. Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
  62. Malignant Solitary Fibrous Tumor of the Liver:AIRP Best Cases in Radiologic-Pathologic Correlation
  63. Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions
  64. Primary intimal sarcoma of the left atrium presenting with constitutional symptoms
  65. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
  66. Epigenetics in endometrial carcinogenesis – part 2: histone modifications, chromatin remodeling and noncoding RNAs
  67. Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study
  68. Epigenetics in endometrial carcinogenesis – part 1: DNA methylation
  69. The role of pathology in the management of patients with endometrial carcinoma
  70. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis
  71. Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer
  72. Adipose Tissue Tumors, Stomach
  73. C-Kit (CD117), Gastrointestinal Stromal Tumors (GISTs)
  74. Distant Metastases in Uterine Leiomyosarcomas
  75. Gastrointestinal Autonomic Nerve Tumor
  76. Gastrointestinal Stromal Tumor
  77. Glomus Tumor, Gastrointestinal
  78. Granular Cell Tumor, Gastrointestinal
  79. Inflammatory Fibroid Polyp, Upper Gastrointestinal Tract
  80. Inflammatory Myofibroblastic Tumor, Upper Gastrointestinal Tract
  81. Neuroendocrine Tumor, Esophagus
  82. Neuroendocrine Tumor, Gastric
  83. Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
  84. Neurocristic hamartoma of the scalp
  85. Solitary squamoid cyst of the liver
  86. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome
  87. TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
  88. Spitz/Reed nevi: a review of clinical-dermatoscopic and histological correlation
  89. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
  90. TERT promoter mutations in pancreatic endocrine tumours are frequent in tumours from patients with hereditary syndromes
  91. Metanephric adenoma: Cytological, histological, and molecular diagnosis of a case
  92. Mixed Adenoneuroendocrine Carcinoma Causing Colonic Intussusception
  93. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium
  94. Basal cell carcinoma of the skin (part 1): epidemiology, pathology and genetic syndromes
  95. Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management
  96. “A book should not be judged by its cover”: two cases of intestinal adenocarcinoma as the first manifestation of Crohn’s disease
  97. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors
  98. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy
  99. LÚPUS ERITEMATOSO CUTÂNEO - CORRELAÇÃO CLÍNICOPATOLÓGICA DE MANIFESTAÇÕES CUTÂNEAS ESPECÍFICAS
  100. RE: TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
  101. Endometrial Carcinoma in Portugal
  102. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide
  103. Pathophysiology of Infantile Pulmonary Arterial Hypertension Induced by Monocrotaline
  104. Pathology, therapy and prognosis of papillary renal carcinoma
  105. AIRP Best Cases in Radiologic-Pathologic Correlation: Gastroblastoma: A Rare Biphasic Gastric Tumor
  106. Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
  107. Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial
  108. TERT Promoter Mutations in Skin Cancer: The Effects of Sun Exposure and X-Irradiation
  109. Telomerase promoter mutations in cancer: an emerging molecular biomarker?
  110. Prognostic significance of TERT promoter mutations in follicular cell-derived thyroid carcinomas
  111. Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death
  112. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas
  113. Human papillomaviruses in intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva
  114. PNET with neuroendocrine differentiation of the lung
  115. Tactoid body features in a Schwann cell hamartoma of colonic mucosa
  116. Frequency of TERT promoter mutations in human cancers
  117. GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
  118. Feasibility of Fine-Needle Aspiration in the Diagnosis of Two Unusual Childhood Jaw Tumor Types: Prognoma and Cementifying Fibroma
  119. Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
  120. Multiple Hepatic Inflammatory Pseudotumours Diagnosed after Laparoscopic Excisional Biopsy
  121. Simultaneous presentation of Kaposi sarcoma and HHV8-associated large B-cell lymphoma in the same lymph node: A rare diagnosis in an HIV-negative patient
  122. Front & Back Matter
  123. Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness
  124. Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma
  125. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors
  126. Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature
  127. mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
  128. 295 Protein Kinase WNK2 Was Correlated With Poor Outcome and Malignant Behavior in Glioma Cell Lines
  129. Insights into melanoma: targeting the mTOR pathway for therapeutics
  130. Surgical Treatment of Gastrointestinal Stromal Tumors (GISTs)
  131. The mTOR Signalling Pathway in Human Cancer
  132. Melanocytic Tumour in a Black Sheep never exposed to Ultraviolet Radiation
  133. Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
  134. A Clear Cell Renal Cell Carcinoma Inhibiting the Response to Intravitreal Antivascular Endothelial Growth Factor Therapy in Wet Age-Related Macular Disease
  135. Paraganglioma of seminal vesicle and chromophobe renal cell carcinoma: a case report and literature review
  136. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms
  137. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
  138. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
  139. ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
  140. ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
  141. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors
  142. Author Index Vol. 95, No. 2
  143. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad
  144. Abdominal inflammatory myofibroblastic tumor
  145. Endometrial Carcinomas
  146. Ascites as a Presenting Sign of Disseminated Tuberculosis in an Immunocompetent Patient
  147. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome
  148. Plenary Oral Free Paper Sessions
  149. Black esophagus
  150. Vascular Ehlers-Danlos syndrome: A case with fatal outcome
  151. Human Endometrium Ultrastructure During the Implantation Window
  152. Identification of De Novo Germline Mutations in the HRPT2 Gene in Two Apparently Sporadic Cases with Challenging Parathyroid Tumor Diagnoses
  153. Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification
  154. Sarcoma pleomórfico primário do pulmão — 11 anos de sobrevivência
  155. Primary pleomorphic sarcoma of lung – 11 year survival
  156. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics
  157. Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
  158. Idiopathic Infantile Arterial Calcification: A Rare Cause of Sudden Unexpected Death in Childhood
  159. 78 Analysis of raf kinase inhibitor protein (RKIP) expression as a prognostic marker for glioblastomas
  160. 95 Associations between functional EGFR polymorphisms and glioma risk
  161. Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours
  162. Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
  163. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma
  164. Angiogenesis and Breast Cancer
  165. ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors
  166. ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors
  167. ENETS Consensus Guidelines for the Management of Brain, Cardiac and Ovarian Metastases from Neuroendocrine Tumors
  168. Author Index Vol. 91, 2010
  169. Densidade microvascular e prognóstico de tumores neuro-endócrinos gastro-entero-pancreáticos
  170. Requisitos mínimos para um relatório de Anatomia Patológica de tumores neuroendócrinos.
  171. Contents Vol. 91, 2010
  172. Subject Index Vol. 91, 2010
  173. Effects of Diabetes Mellitus, Pressure-Overload and Their Association on Myocardial Structure and Function
  174. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
  175. Loss of RKIP expression is associated with poor survival in GISTs
  176. Epidermolytic hyperkeratosis with palmoplantar keratoderma in a patient with KRT10 mutation
  177. Low frequency of MAP kinase pathway alterations inKITandPDGFRAwild-type GISTs
  178. Low-Grade Endometrial Stromal Sarcoma and Undifferentiated Endometrial Sarcoma: A Comparative Analysis Emphasizing the Importance of Distinguishing Between These Two Groups
  179. TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset
  180. Características clínico-laboratoriais e sobrevida em doentes com tumores neuroendócrinos do estômago
  181. Restrictive dermopathy—a lethal congenital laminopathy. Case report and review of the literature
  182. Cryptic chromosome rearrangement resulting in SYT-SSX2 fusion gene in a monophasic synovial sarcoma
  183. 583 POSTER Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs
  184. Clinicopathological features of 45,X/46,Xidic(Y) mosaicism and therapeutic implications: case report
  185. Surgical Margin Status and Prognosis of Gastrointestinal Stromal Tumor
  186. Clear Cell Change in Colonic Polyps
  187. Composite Adenomatoid Tumor and Myelolipoma of Adrenal Gland: Report of 2 Cases
  188. Epithelial-myoepithelial parotid carcinoma after kidney transplantation
  189. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas
  190. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
  191. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma
  192. Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary
  193. Author Index Vol. 87, No. 1, 2008
  194. Title Page / Table of Contents
  195. Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin
  196. Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Tumour/Carcinoma of the Appendix and Goblet Cell Carcinoma
  197. Splenic hamartomas in a dog
  198. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series
  199. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system
  200. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation
  201. Association between Functional EGF+61 Polymorphism and Glioma Risk
  202. Multiple Myeloma Presenting with Malabsorption
  203. Gastrinoma (Duodenal and Pancreatic)
  204. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
  205. Rare Functioning Pancreatic Endocrine Tumors
  206. Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)
  207. Well-Differentiated Gastric Tumors/Carcinomas
  208. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma
  209. Orbital Metastasis as a Rare Form of Clinical Presentation of Non-small Cell Lung Cancer
  210. Deep-Seated Congenital Juvenile Xanthogranuloma
  211. Determining the least time required for measuring energy expenditure in premature neonates
  212. An infant with bullous pemphigoid
  213. Molecular Alterations of KIT Oncogene in Gliomas
  214. 183 POSTER Molecular alterations of KIT and PDGFR-alpha; in GISTs - A Portuguese experience
  215. Fluid supplementation for neonatal hyperbilerubinemia
  216. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
  217. Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen
  218. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma
  219. Title Page / Table of Contents
  220. Author Index Vol. 84, No. 3, 2006
  221. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors
  222. Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum
  223. Gingival Hyperplasia as a First Manifestation of Crohn's Disease
  224. Colonic Gastrointestinal Autonomic Nervous Tumor in a Patient with Crohn’s Disease
  225. Esophageal Gist: Therapeutic implications of an uncommon presentation of a rare tumor
  226. Epithelioid hemangioendothelioma and multiple thoraco-lumbar lateral meningoceles: two rare pathological entities in a patient with NF-1
  227. Molecular Characterization of PDGFR‐α/PDGF‐A and c‐KIT/SCF in Gliosarcomas
  228. Mutation analysis of B-RAF gene in human gliomas
  229. Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma
  230. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia
  231. 31. Biopsia aspirativa transtorácica por agulha fina para o diagnóstico de lesões pulmonares
  232. Lipomatous haemangiopericytoma (adipocytic variant of solitary fibrous tumour) of the thyroid
  233. Pathologic Quiz Case: A 53-Year-Old Man With a Slowly Enlarging Mass in the Right Leg
  234. Primary Cutaneous Malignant Melanoma With Lipoblast-like Cells
  235. Cutaneous Malignant Melanoma: The Great Simulator
  236. Expression of c-met Tyrosine Kinase Receptor Is Biologically and Prognostically Relevant for Primary Cutaneous Malignant Melanomas
  237. Intraclonal diversity in a Sezary syndrome with a differential response to 2-deoxycoformycin of the two lymphoma cell populations
  238. Pathologic Quiz Case: A 36-Year-Old Woman With Muscle Pain and Weakness
  239. Classic Kaposi's sarcoma of the tongue: Case report with emphasis on the differential diagnosis
  240. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  241. Idiopathic Perforation of the Gallbladder: A Novel Differential Diagnosis of Acute Abdomen
  242. Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin
  243. Carcinoma secretor da mama no adulto: existem parâmetros bem definidos para decisão terapêutica?
  244. Congenital composite hemangioendothelioma: case report and reappraisal of the hemangioendothelioma spectrum
  245. Response to Cyclosporine in a Patient With Disseminated Granuloma Annulare Associated With CD4+/CD8+(dim)/CD56+ Large Granular Lymphocytic Leukemia
  246. Chronic Eosinophilic Leukaemia Presenting with Erythroderma, Mild Eosinophilia and Hyper-IgE: Clinical, Immunological and Cytogenetic Features and Therapeutic Approach
  247. Hyaline Cell-rich Chondroid Syringoma: Case Report and Review of the Literature
  248. Subject Index, Vol. 107, No. 2, 2002
  249. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient
  250. Primary acinic cell-like carcinoma of the breast-a variant with good prognosis?
  251. Genetic Profile of Gliosarcomas
  252. Adenocarcinoma of the cervix
  253. Microsatellite instability is not associated with degree of malignancy and p53 expression of gastrointestinal stromal tumours
  254. Esophageal inflammatory pseudotumor associated with a pseudodiverticulosis cyst: two inter-related lesions?
  255. Time of remodelling of the patella tendon graft in anterior cruciate ligament surgery: an histological and immunohistochemical study in a rabbit model
  256. Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki‐67) Markers
  257. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins
  258. Synovial sarcoma: immunohistochemical expression of p-glycoprotein and glutathione s-transferase-pi and clinical drug resistance
  259. Critical Commentary
  260. Critical Commentary
  261. Proliferative Activity of Synovial Sarcoma: An Immunohistochemical Evaluation of Ki-67 Labeling Indices of 52 Primary and Recurrent Tumors
  262. Immunohistochemical Profile of Synovial Sarcoma with Emphasis on the Epithelial-type Differentiation
  263. Phacolytic glaucoma and lens-induced uveitis
  264. Critical Commentary
  265. Critical Commentary
  266. Primary liver cancer in genetic hemochromatosis: A clinical, pathological, and pathogenetic study of 54 cases
  267. The Ultrastructural Spectrum of Synovial Sarcomas: A Study of the Epithelial Type Differentiation of Primary Tumors, Recurrences, and Metastases
  268. Congenital Hereditary Corneal Dystrophy: Histologic and Ultrastructural Assessment of a Peculiar Polimorphic Recessive Form
  269. Dermatofibrosarcoma Protuberans
  270. Round cell sarcoma after clear cell sarcoma remission
  271. Thymic Tumors
  272. Abnormal Organization of the Human Retina in a Genetic Disorder (Bloch-Sulzberger Syndrome)
  273. Cytogenetic study of a sclerosing stromal tumor of the ovary
  274. Common arterial trunk associated with absence of one atrioventricular connexion